Pharmalogic Syracuse, LLC
Syracuse, NY Part of Pharmalogic Holdings Corp.
- UEI
- PNF5PJRFG3M7
- CAGE
- 3YWX3
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Pharmalogic Holdings Corp., ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Pharmalogic Holdings Corp. · Boca Raton, FL
HVFXH4DBMXF2
-
Parent
Pharmalogic Holdings Corp. · Boca Raton, FL
HVFXH4DBMXF2
- SAM.gov registration date
- Physical address
- 6464 Ridings Rd Suite 101, Syracuse, NY 13206, USA
- Website
- radiopharmacy.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $141,413 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Pharmalogic WY Inc. | Bridgeport, WV | 325412 Pharmaceutical Preparation Manufacturing |
| Radiopharmacy Of Indianapolis | Indianapolis, IN | 325412 Pharmaceutical Preparation Manufacturing |
| Heartlight Pharmacy Services | Lima, OH | 325412 Pharmaceutical Preparation Manufacturing |
| Nuclear Diagnostic Products, Inc. | Rockaway, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Hot Shots Nuclear Medicine | Lansing, MI | 325412 Pharmaceutical Preparation Manufacturing |
About the company
Pharmalogic Syracuse, LLC is a for-profit limited liability company registered to receive federal contract awards since July 29, 2004. The company specializes in providing radiopharmaceuticals to the U.S. federal government, particularly to the Department of Veterans Affairs (VA) Veterans Health Administration. As a supplier of critical medical products, Pharmalogic Syracuse plays an important role in supporting nuclear medicine departments within VA medical centers. The company's expertise in radiopharmaceuticals indicates its significance in the healthcare supply chain, specifically in diagnostic and therapeutic nuclear medicine procedures.
The federal contract awards received by Pharmalogic Syracuse, LLC demonstrate its consistent involvement in supplying radiopharmaceuticals to VA medical facilities. In April 2024, the company was awarded a contract with a ceiling value of $141,413.26 to provide radiopharmaceuticals to the Veterans Integrated Service Network 2, with performance through June 30, 2024. This contract is part of a larger indefinite delivery vehicle (IDV) with a ceiling value of $3,800,294.96. Previously, in October 2020, Pharmalogic Syracuse received a purchase order worth $54,968.84 from the Veterans Integrated Service Network 1 for radiopharmaceuticals, with completion in February 2022. These awards highlight the company's ongoing relationship with the VA and its ability to meet the specialized needs of nuclear medicine departments across different VA networks.
Pharmalogic Syracuse, LLC currently holds a significant federal contract IDV awarded by the Veterans Integrated Service Network 2. This single-award indefinite delivery contract, valued at $3,800,294.96, was awarded on April 1, 2024, with an ultimate completion date of June 30, 2024, and the potential for four option years. Under this IDV, Pharmalogic Syracuse is responsible for supplying a wide range of radiopharmaceutical products to the Albany VA Medical Center Nuclear Medicine department. These products include various compounds such as technetium, iodine, thallium, and gallium, used in diverse nuclear medicine procedures. The contract also covers specialized radiopharmaceuticals for procedures like WBC labeling, cardiac imaging, and therapy. Additionally, a firm-fixed-price delivery order has been issued under this IDV, valued at $153,966.42, with a performance period through March 31, 2025. This comprehensive IDV underscores Pharmalogic Syracuse's capability to serve as a primary supplier of radiopharmaceuticals for the VA's nuclear medicine needs.
Quick answers
Is Pharmalogic Syracuse, LLC registered in SAM.gov?
Yes. Pharmalogic Syracuse, LLC's SAM.gov registration is active through December 22, 2026.
How much has Pharmalogic Syracuse, LLC received in federal contracts?
Federal contracts obligated $141,413 to Pharmalogic Syracuse, LLC in fiscal years 2023 through 2027.
How does Pharmalogic Syracuse, LLC rank among federal contractors?
Pharmalogic Syracuse, LLC's parent company, Pharmalogic Holdings Corp., ranked #30 in NAICS 325412, #41 in PSC 6505 and #42 in NAICS 3254 in FY2025.
What is Pharmalogic Syracuse, LLC's most recent federal award?
Pharmalogic Syracuse, LLC's most recent federal contract award is Radiopharmaceuticals (36C24224N0372), from Veterans Integrated Service Network 2 (VHA), on April 1, 2024.
On GovTribe
See Pharmalogic Syracuse, LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors